{"filing":{"accession_number":"0001104659-26-082871","cik":"0001321851","ticker":"SEED","company_name":"Origin Agritech LTD","form":"6-K","filing_date":"2026-07-13","report_date":null,"primary_document":"tm2620133d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1321851/000110465926082871/tm2620133d1_6k.htm"},"events":[{"id":17486,"run_id":15662,"accession_number":"0001104659-26-082871","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This exhibit is a corporate presentation detailing Origin Agritech's turnaround strategy, leadership changes, R\u0026D pipeline, and commercialization roadmap. While it includes executive appointments (CEO Weibin Yan in August 2024, CFO Dr. James Chen and Board member Dr. Jian Zhang in March 2026), the primary focus is on operational and strategic initiatives—market-oriented breeding, biotech commercialization, sales network rebuilding, supply chain upgrades, and a multi-year growth strategy (2024–2032). The disclosure emphasizes operational transformation and product development rather than discrete executive events. This is material to investors assessing the company's turnaround execution and competitive positioning in China's seed industry.","company_name":"Origin Agritech LTD","ticker":"SEED","filing_date":"2026-07-13","form":"6-K","submitted_at":null,"items":[{"id":15982,"accession_number":"0001104659-26-082871","item_number":"EX-99.1","item_title":"tm2620133d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This exhibit is a corporate presentation detailing Origin Agritech's turnaround strategy, leadership changes, R\u0026D pipeline, and commercialization roadmap. While it includes executive appointments (CEO Weibin Yan in August 2024, CFO Dr. James Chen and Board member Dr. Jian Zhang in March 2026), the primary focus is on operational and strategic initiatives—market-oriented breeding, biotech commercialization, sales network rebuilding, supply chain upgrades, and a multi-year growth strategy (2024–2032). The disclosure emphasizes operational transformation and product development rather than discrete executive events. This is material to investors assessing the company's turnaround execution and competitive positioning in China's seed industry.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T11:34:38.348803+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15982,"accession_number":"0001104659-26-082871","item_number":"EX-99.1","item_title":"tm2620133d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This exhibit is a corporate presentation detailing Origin Agritech's turnaround strategy, leadership changes, R\u0026D pipeline, and commercialization roadmap. While it includes executive appointments (CEO Weibin Yan in August 2024, CFO Dr. James Chen and Board member Dr. Jian Zhang in March 2026), the primary focus is on operational and strategic initiatives—market-oriented breeding, biotech commercialization, sales network rebuilding, supply chain upgrades, and a multi-year growth strategy (2024–2032). The disclosure emphasizes operational transformation and product development rather than discrete executive events. This is material to investors assessing the company's turnaround execution and competitive positioning in China's seed industry.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T11:34:38.348803+00:00","company_name":"Origin Agritech LTD","ticker":"SEED","filing_date":"2026-07-13"}]}